Cyclo Therapeutics, Inc. (CYTH) NASDAQ

0.72

+0(+0.00%)

Updated at March 26 04:00PM

Currency In USD

Valuation

Market Cap25.96M
Enterprise Value17.75M
P/E Ratio-1.08
PEG Ratio0.48
Price/Sales Ratio42.18
Price/Book Ratio-1.54
Enterprise/Revenue62.34
Enterprise/EBITDA-1.83

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-34.25
Operating Margin-34.03

Management Effectiveness

Return On Assets-3.65
Return On Equity3.2

Income Statement

Revenue1.08M
Revenue/Share0.02
Gross Profit977,947
EBITDA-20.03M
Net Income-20.06M
Diluted EPS-1.23

Balance Sheet

Total Cash928,010
Total Cash/Share0.03
Total Debt12.21M
Total Debt/Equity-0.91
Current Ratio0.17
Book Value Per Share-0.47

Price History

52-Week Change-44.14
52-Week High1.62
52-Week Low0.55
Moving Average 50 Days0.8
Moving Average 200 Days0.83

Statistics

Average Volume1.76M
Shares Outstanding32.74M
% Held by Institutions7.49

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:100
Last Split DateDecember 09, 2020